Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16252-16257
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16252
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16252
Table 1 Proposed tumor-node-metastasis classification for neuroendocrine tumors of the rectum (European Neuroendocrine Tumor Society 2007)[7]
TNM classification | |
T: Primary tumor | |
Tx | Primary tumor cannot be assessed |
T0 | No evidence of primary tumor |
T1 | Tumor invades the mucosa or submucosa and size ≤ 1 cm |
T1a: size < 1 cm | |
T1b: size 1-2 cm | |
T2 | Tumor invades the muscularis propria or size > 2 cm |
T3 | Tumor invades subserosa/pericolic/perirectal fat |
T4 | Tumor directly invades other organs/structures and/or perforates the visceral peritoneum |
N: Regional lymph nodes | |
Nx | Regional lymph nodes cannot be assessed |
N0 | No regional lymph node metastasis |
N1 | Regional lymph node metastasis |
M: Distant metastasis | |
MX | Distant metastasis cannot be assessed |
M0 | No distant metastases |
M1 | Distant metastasis |
- Citation: Chi Y, Du F, Zhao H, Wang JW, Cai JQ. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors. World J Gastroenterol 2014; 20(43): 16252-16257
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16252.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16252